Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Foroud Shahbazi, Lida Shojaei, Fakhrossadat Farvadi & Sara Kadivarian. (2022) Antimicrobial safety considerations in critically ill patients: part II: focused on anti-microbial toxicities. Expert Review of Clinical Pharmacology 15:5, pages 563-573.
Read now
Read now
Marios Karvouniaris, Konstantinos Pontikis, Thomas Nitsotolis & Garyphallia Poulakou. (2021) New perspectives in the antibiotic treatment of mechanically ventilated patients with infections from Gram-negatives. Expert Review of Anti-infective Therapy 19:7, pages 825-844.
Read now
Read now
Norelle Sherry & Benjamin Howden. (2018) Emerging Gram negative resistance to last-line antimicrobial agents fosfomycin, colistin and ceftazidime-avibactam – epidemiology, laboratory detection and treatment implications. Expert Review of Anti-infective Therapy 16:4, pages 289-306.
Read now
Read now
Articles from other publishers (20)
Sara Grillo, Miquel Pujol, Josep M. Miró, Joaquín López-Contreras, Gorane Euba, Oriol Gasch, Lucia Boix-Palop, Maria José Garcia-País, Maria Teresa Pérez-Rodríguez, Silvia Gomez-Zorrilla, Isabel Oriol, Luis Eduardo López-Cortés, Maria Luisa Pedro-Botet, Rafael San-Juan, José María Aguado, Francesca Gioia, Simona Iftimie, Laura Morata, Alfredo Jover-Sáenz, Graciano García-Pardo, Belén Loeches, Álvaro Izquierdo-Cárdenas, Ane Josune Goikoetxea, Aina Gomila-Grange, Beatriz Dietl, Damaris Berbel, Sebastian Videla, Pilar Hereu, Ariadna Padullés, Natalia Pallarès, Cristian Tebé, Guillermo Cuervo, Jordi Carratalà, Maria Alba Rivera, Malen Aguirregabiria, Regino Rodríguez-Álvarez, María José Blanco-Vidal, Marina Alguacil-Guillen, Mariona Xercavins, Virginia Pomar, Ana Siverio-Parés, Marina de Cueto, Elisa Moreno-Mellado, Adrián Sousa, Francisco José Vasallo-Vidal, Beatriz Borjabad, Ana Coloma-Conde, Raquel Clivillé-Abad, Sabina Ximena González-di Lauro, Jose Tiago-Silva, Maria Angeles Orellana, Mario Ruíz-Bastián, Pilar Vizcarra, Carles Garcia, Frédéric Ballester, María Fernanda Ramírez-Hidalgo, Alba Bellés-Bellés, Yolanda Meije, Alba Ribera, Jaume LLaberia, María Ángeles Domínguez, Raul Francisco Rigo-Bonnin, Gertrudis Horna, Dominica Mediavilla, Mireia Sanllorente, Ester Picó-Plana, Alex Soriano, Cristina Pitart & Ana Maria Sanchez-Diaz. (2023) Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial. Nature Medicine 29:10, pages 2518-2525.
Crossref
Crossref
Tugba SARI, Şükran KÖSE, Hüseyin TURGUT, Müge ÖZGÜLER, Sinem AKKAYA IŞIK & Ayşe ÖZKAN ACAR. (2023) Clinical Value Of Intravenous Fosfomycin Combinationsİntravenöz Fosfomisin Kombinasyonlarının Klinik Değeri. İzmir Tıp Fakültesi Dergisi.
Crossref
Crossref
Alessandro Russo, Antonio Vena & Matteo Bassetti. (2022) Antibiotic treatment of acute bacterial skin and skin structure infections. Current Opinion in Infectious Diseases 35:2, pages 120-127.
Crossref
Crossref
Alessandro Russo, Enrico Maria Trecarichi & Carlo Torti. (2022) The role of Gram-negative bacteria in skin and soft tissue infections. Current Opinion in Infectious Diseases 35:2, pages 95-102.
Crossref
Crossref
Cristina Scavone, Annamaria Mascolo, Francesca Futura Bernardi, Maria Luisa Aiezza, Paola Saturnino, Gaia Morra, Margherita Simonelli, Marida Massa, Andrea Pomicino, Giuseppina Minei, Raffaella Pisapia, Micaela Spatarella, Ugo Trama, Gaspare Guglielmi, Annalisa Capuano & Alessandro Perrella. (2022) Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database. Frontiers in Pharmacology 13.
Crossref
Crossref
Tasneem A.K. Abdallah, Reem Elajez, Tawheeda B. Ibrahim, Abeir B. Alimam & Ali S. Omrani. (2021) Efficacy and safety of intravenous fosfomycin for the treatment of difficult-to-treat Gram-negative bacterial infections. Journal of Infection and Public Health 14:11, pages 1620-1622.
Crossref
Crossref
Cristiane dos Santos, Lucas Souza dos Santos & Octávio Luiz Franco. (2021) Fosfomycin and nitrofurantoin: classic antibiotics and perspectives. The Journal of Antibiotics 74:9, pages 547-558.
Crossref
Crossref
Fatih TEMOÇİN, Levent ŞENSOY, Tuba KURUOĞLU, Aynur ATİLLA & Esra TANYEL. (2021) Eski bir molekül, yeni bir ilaç; intravenöz Fosfomisinin klinik kullanımdaki yeri. Pamukkale Medical Journal.
Crossref
Crossref
Weerayuth Saelim, Dhitiwat Changpradub, Sudaluck Thunyaharn, Piraporn Juntanawiwat, Parnrada Nulsopapon & Wichai Santimaleeworagun. (2021)
Colistin plus Sulbactam or Fosfomycin against Carbapenem-Resistant
Acinetobacter baumannii
: Improved Efficacy or Decreased Risk of Nephrotoxicity?
. Infection & Chemotherapy 53:1, pages 128.
Crossref
Crossref
Wenya Xu, Tao Chen, Huihui Wang, Weiliang Zeng, Qing Wu, Kaihang Yu, Ye Xu, Xiucai Zhang & Tieli Zhou. (2020) Molecular Mechanisms and Epidemiology of Fosfomycin Resistance in Staphylococcus aureus Isolated From Patients at a Teaching Hospital in China. Frontiers in Microbiology 11.
Crossref
Crossref
Sukrit Kanchanasurakit, Wichai Santimaleeworagun, Charles E. McPhersonIIIIII, Napacha Piriyachananusorn, Benjawan Boonsong, Papanin Katwilat & Surasak Saokaew. (2020)
Fosfomycin Dosing Regimens based on Monte Carlo Simulation for Treated Carbapenem-Resistant
Enterobacteriaceae
Infection
. Infection & Chemotherapy 52:4, pages 516.
Crossref
Crossref
Matteo Bassetti, Elena Graziano, Marco Berruti & Daniele Roberto Giacobbe. (2019) The role of fosfomycin for multidrug-resistant gram-negative infections. Current Opinion in Infectious Diseases 32:6, pages 617-625.
Crossref
Crossref
Rodrigo M Burgos & Keith A Rodvold. (2019) ZTI-01 (fosfomycin for injection) in the treatment of hospitalized patients with complicated urinary tract infections. Future Microbiology 14:6, pages 461-475.
Crossref
Crossref
Paola Del Giacomo, Angela Raffaella Losito & Mario Tumbarello. (2019) The role of carbapenem-resistant pathogens in cSSTI and how to manage them. Current Opinion in Infectious Diseases 32:2, pages 113-122.
Crossref
Crossref
Balaji Veeraraghavan, Agila Kumari Pragasam, Yamuna Devi Bakthavatchalam, Shalini Anandan, Subramanian Swaminathan & Balasubramanian Sundaram. (2019) Colistin-Sparing Approaches with Newer Antimicrobials to Treat Carbapenem-Resistant Organisms: Current Evidence and Future Prospects. Indian Journal of Medical Microbiology 37:1, pages 72-90.
Crossref
Crossref
Nieves M. Coronado-Álvarez, Diego Parra & Jorge Parra-Ruiz. (2019) Clinical efficacy of fosfomycin combinations against a variety of gram-positive cocci. Enfermedades infecciosas y microbiologia clinica (English ed.) 37:1, pages 4-10.
Crossref
Crossref
Nieves M. Coronado-Álvarez, Diego Parra & Jorge Parra-Ruiz. (2019) Clinical efficacy of fosfomycin combinations against a variety of gram-positive cocci. Enfermedades Infecciosas y Microbiología Clínica 37:1, pages 4-10.
Crossref
Crossref
Mario Tumbarello, Angela Raffaella Losito & Helen Giamarellou. (2018) Optimizing therapy in carbapenem-resistant Enterobacteriaceae infections. Current Opinion in Infectious Diseases 31:6, pages 566-577.
Crossref
Crossref
Athina Pyrpasopoulou, Georgia Pitsava, Elias Iosifidis, George Imvrios, Eleni Massa, Eleni Mouloudi, Ioannis Goulis, Eleni Chatzidrosou, Charalampos Antachopoulos, Ioannis Fouzas & Emmanuel Roilides. (2018) Intravenous fosfomycin in patients with liver disease for extensively drug-resistant Gram-negative bacteria. Journal of Infection 77:5, pages 448-454.
Crossref
Crossref
Wouter van den Bijllaardt, Maarten J Schijffelen, Ron W Bosboom, James Cohen Stuart, Bram Diederen, Greetje Kampinga, Thuy-Nga Le, Ilse Overdevest, Frans Stals, Paul Voorn, Karola Waar, Johan W Mouton & Anouk E Muller. (2018) Susceptibility of ESBL Escherichia coli and Klebsiella pneumoniae to fosfomycin in the Netherlands and comparison of several testing methods including Etest, MIC test strip, Vitek2, Phoenix and disc diffusion. Journal of Antimicrobial Chemotherapy 73:9, pages 2380-2387.
Crossref
Crossref